Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
2
×
biotech
boston
boston blog main
boston top stories
clinical trials
crispr
cynthia collins
editas medicine
gene editing
life sciences
national blog main
abbvie
alzheimer's disease
deals
drugs
katrine bosley
leber congenital amaurosis
leber congenital amaurosis type 10
michelle robertson
parkinson's disease
rare diseases
san francisco blog main
voyager therapeutics
What
editas
editing
experimental
2
×
gene
abbvie
allergan
alliance
biotech
blessing
bosley
ceo
check
clinical
crispr
cusp
depart
exits
genetic
humans
katrine
medicine
medicines
million
pact
partner
partnership
pruning
regulatory
research
returning
rights
terminated
test
therapy
treatment
trial
Language
unset
Current search:
allergan
×
experimental
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
